GLPwatch

The Effect of Different Diets on Arterial Stiffness in Obese Patients on Semaglutide

NCT04990024 · Recruiting

Last updated 2026-05-28

This clinical trial is testing how different diets affect blood vessel stiffness in obese adults who are taking the medication semaglutide.

Status Recruiting Currently enrolling participants.
Phase Not applicable Not a phased drug trial (e.g. a device or behavioral study).
Type Interventional (clinical trial)
Design Randomized, open-label (no blinding) treatment study
Participants 60 people Planned (estimated).
Who can join Ages 18–49 · all sexes Healthy volunteers accepted.
Timeline Started 2021-07 · est. completion 2025-09
Where 1 site · Lebanon

What this study is testing ClinicalTrials.gov NCT04990024 ↗

Description as written by the study sponsor.

In patients initiating Semaglutide for weight management, the objective is to compare the effect of the Mediterranean diet and the high protein/low carbohydrate (HP/LC) diet CV parameters, namely arterial stiffness, measured by carotid-femoral pulse wave velocity (cfPWV), and visceral adipose tissue, in addition to other metabolic indicators.

Treatments tested

Main thing measuredcfPWV measurement and pulse wave analysis (PWA) using SphygmoCorCvMS V9 (AtCor Medical)
SponsorAmerican University of Beirut Medical Center
Conditions studiedObesity, Weight Loss
GLP-1 drugs semaglutide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT04990024 ↗